Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7828)
All Articles published online
|
Sep 26, 2011 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lefranc F, Mathieu V, Kiss R. Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior. World J Biol Chem 2011; 2(9): 193-201 [PMID: 21949569 DOI: 10.4331/wjbc.v2.i9.193] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v2/i9/193.htm |
| Number | Citing Articles |
| 1 |
Brian A. Boone, Michael T. Lotze. Molecular Diagnostics for Melanoma. Methods in Molecular Biology 2014; 1102: 537 doi: 10.1007/978-1-62703-727-3_29
|
| 2 |
Florence Lefranc, Véronique Mathieu, Robert Kiss. Galectin-1 as an oncotarget in gliomas and melanomas. Oncotarget 2011; 2(12): 892 doi: 10.18632/oncotarget.408
|
| 3 |
Nathan Koonce, Robert Griffin, Ruud Dings. Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models. International Journal of Molecular Sciences 2017; 18(12): 2671 doi: 10.3390/ijms18122671
|
| 4 |
Anatole A. Klyosov, Peter G. Traber. Galectins and Disease Implications for Targeted Therapeutics. ACS Symposium Series 2012; 1115: 3 doi: 10.1021/bk-2012-1115.ch001
|
| 5 |
Laura M. Epple, Rebecca D. Dodd, Andrea L. Merz, Anjelika M. Dechkovskaia, Matthew Herring, Benjamin A. Winston, Alex M. Lencioni, Rae L. Russell, Helen Madsen, Meheret Nega, Nathaniel L. Dusto, Jason White, Darell D. Bigner, Christopher V. Nicchitta, Natalie J. Serkova, Michael W. Graner, Tao Jiang. Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells. PLoS ONE 2013; 8(8): e73267 doi: 10.1371/journal.pone.0073267
|
| 6 |
Helle Jensen, Michael Hagemann-Jensen, Felicia Lauridsen, Søren Skov. Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment. Molecular Immunology 2013; 53(3): 255 doi: 10.1016/j.molimm.2012.08.011
|
| 7 |
Iris A. Schulkens, Arjan W. Griffioen, Victor L. Thijssen. Galectins and Disease Implications for Targeted Therapeutics. ACS Symposium Series 2012; 1115: 233 doi: 10.1021/bk-2012-1115.ch013
|
| 8 |
Maria C. Gomes, Juan Chen, Angela Cunha, Tito Trindade, Gang Zheng, João P. C. Tomé. Complex cellular environments imaged by SERS nanoprobes using sugars as an all-in-one vector. Journal of Materials Chemistry B 2021; 9(45): 9285 doi: 10.1039/D1TB01360B
|
| 9 |
Erin Sykes, Swetlana Mactier, Richard Christopherson. Melanoma and the Unfolded Protein Response. Cancers 2016; 8(3): 30 doi: 10.3390/cancers8030030
|
| 10 |
Anatole A. Klyosov. Glycobiology and Drug Design. ACS Symposium Series 2012; 1102: 25 doi: 10.1021/bk-2012-1102.ch002
|
| 11 |
J. Ye, H. Liu, Y. Hu, G. Wan, J. Li, Z. Wang, P. Li, G. Zhang, Y. Li. The clinical implication of tumoral Gal-1 expression in laryngeal squamous cell carcinomas. Clinical and Translational Oncology 2013; 15(8): 608 doi: 10.1007/s12094-012-0975-z
|
| 12 |
Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Robert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan W. Van Gool, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01279-1
|
| 13 |
Gao-Feng Xu, Wan-Fu Xie. Effect of ERBB2 expression on invasiveness of glioma TJ905 cells. Asian Pacific Journal of Tropical Medicine 2013; 6(12): 964 doi: 10.1016/S1995-7645(13)60172-8
|
| 14 |
Ewa Cieckiewicz, Véronique Mathieu, Luc Angenot, Thierry Gras, Bieke Dejaegher, Pascal de Tullio, Bernard Pirotte, Michel Frédérich. Semisynthesis and in Vitro Photodynamic Activity Evaluations of Halogenated and Glycosylated Derivatives of Pheophorbide a. European Journal of Organic Chemistry 2015; 2015(27): 6061 doi: 10.1002/ejoc.201500387
|
| 15 |
Ruud P. M. Dings, Nigam Kumar, Michelle C. Miller, Melissa Loren, Huzaifa Rangwala, Thomas R. Hoye, Kevin H. Mayo. Structure-Based Optimization of Angiostatic Agent 6DBF7, an Allosteric Antagonist of Galectin-1. Journal of Pharmacology and Experimental Therapeutics 2013; 344(3): 589 doi: 10.1124/jpet.112.199646
|
| 16 |
Prarthana Gopinath, Aparna Natarajan, Amritha Sathyanarayanan, Sridevi Veluswami, Gopal Gopisetty. The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets. Gene 2022; 815: 146137 doi: 10.1016/j.gene.2021.146137
|
| 17 |
Jéssica S. Garcia, Nicolle G.T.Q. Hazarbassanov, Júlia C. Nakamura, Victor Nowosh, Bruno Cogliati, Lilian Rose Marques de Sá, Cristina O. Massoco. Evaluation of galectins 1 and 3 expression in canine melanoma. Pesquisa Veterinária Brasileira 2020; 40(12): 1010 doi: 10.1590/1678-5150-pvb-6377
|
| 18 |
Victoria Sundblad, Veronique Mathieu, Robert Kiss, Gabriel A. Rabinovich. Cancer Immunotherapy. 2013; : 537 doi: 10.1016/B978-0-12-394296-8.00031-2
|
| 19 |
Russell R. Braeuer, Einav Shoshan, Takafumi Kamiya, Menashe Bar‐Eli. The sweet and bitter sides of galectins in melanoma progression. Pigment Cell & Melanoma Research 2012; 25(5): 592 doi: 10.1111/j.1755-148X.2012.01026.x
|
| 20 |
Ning Yang, Wenxi Zhang, Tao He, Yiqiao Xing. Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy. Experimental Eye Research 2017; 159: 1 doi: 10.1016/j.exer.2017.02.015
|
| 21 |
Sabrina Rizzolio, Simona Corso, Silvia Giordano, Luca Tamagnone. Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells. Cancers 2020; 12(8): 2218 doi: 10.3390/cancers12082218
|
| 22 |
Masafumi Yamaguchi, Yukihiro Sera, Hanae Toga-Yamaguchi, Hirokazu Kanegane, Yusuke Iguchi, Kingo Fujimura. Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth. International Journal of Hematology 2024; 119(4): 383 doi: 10.1007/s12185-024-03709-z
|